Skip to main content


Aims and scope

Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings.

Addiction Science & Clinical Practice accepts articles of clinical relevance related to the prevention and treatment of unhealthy alcohol, tobacco, and other drug use across the spectrum of clinical settings. Topics of interest address issues related to the following: the spectrum of unhealthy use of alcohol, tobacco, and other drugs among the range of affected persons (e.g., not limited by age, race/ethnicity, gender, or sexual orientation); the array of clinical prevention and treatment practices (from health messages, to identification and early intervention, to more extensive interventions including counseling and pharmacotherapy and other management strategies); and identification and management of medical, psychiatric, social, and other health consequences of substance use.

Addiction Science & Clinical Practice is particularly interested in articles that address how to improve the quality of care for people with unhealthy substance use and related conditions as described in the (US) Institute of Medicine report, Improving the Quality of Healthcare for Mental Health and Substance Use Conditions (Washington, DC: National Academies Press, 2006). Such articles address the quality of care and of health services. Although the journal also welcomes submissions that address these conditions in addiction speciality-treatment settings, the journal is particularly interested in including articles that address unhealthy use outside these settings, including experience with novel models of care and outcomes, and outcomes of research-practice collaborations.

Although Addiction Science & Clinical Practice is generally not an outlet for basic science research, we will accept basic science research manuscripts that have clearly described potential clinical relevance and are accessible to audiences outside a narrow laboratory research field.

New Content ItemWe are proud to acknowledge that over 50% of the articles published in Addiction Science & Clinical Practice in 2023 were related to one or more of the 17 Sustainable Development Goals (SDGs). Springer Nature supports the SDGs through a dedicated SDG Programme and is a signatory of the SDG Publishers Compact.

Archival content

Addiction Science & Clinical Practice was previously published by NIDA and the journal's back content can be viewed here -

Open access

All articles published by Addiction Science & Clinical Practice are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Addiction Science & Clinical Practice you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article processing charges (APC)

Authors who publish open access in Addiction Science & Clinical Practice are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £1990.00/$2690.00/€2290.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

Indexing services

All articles published in Addiction Science & Clinical Practice are included in:

  • Citebase
  • DOAJ
  • Emerging Sources Citation Index (ESCI)
  • OAIster
  • PubMed
  • Scopus
  • Zetoc

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Addiction Science & Clinical Practice will be available in their databases when appropriate.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Addiction Science & Clinical Practice operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Editorial policies

All manuscripts submitted to Addiction Science & Clinical Practice should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Addiction Science & Clinical Practice

Articles in Addiction Science & Clinical Practice  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Addict Sci Clin Pract [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Addict Sci Clin Pract 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Benefits of publishing with BMC

High visibility

Addiction Science & Clinical Practice's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Addiction Science & Clinical Practice offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.


Online publication in Addiction Science & Clinical Practice gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Addiction Science & Clinical Practice are included in article alerts and regular email updates. Some may be highlighted on Addiction Science & Clinical Practice’s pages and on the BMC homepage.

In addition, articles published in Addiction Science & Clinical Practice may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Addiction Science & Clinical Practice. A list of articles recently press-released by journals published by BMC is available here.


As an author of an article published in Addiction Science & Clinical Practice you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.

The Farmington Consensus

Addiction Science & Clinical Practice adheres to the ethical guidelines for scientific publishing outlined in the Farmington Consensus. The Consensus is a series of ethical guidelines for addiction journals developed in 1997 at the inaugural meeting of the group now known as the International Society of Addiction Journal Editors (ISAJE). The resulting document can be found in draft form here. The purpose of the guidelines is to provide guidance to authors, editors and other individuals on ethical and procedural matters that affect the integrity of scientific publishing in the addiction field. We urge readers, writers, reviewers of Addiction Science & Clinical Practice to study the guidelines, to criticize them, to improve them, and to use them effectively.

A note on addiction terminology

The editors of Addiction Science & Addiction Science advise authors to avoid the terms "MAT" or "medication-assisted treatment". The editors instead recommend using "MOUD" or "medications for opioid use disorder". For further reading, please see Friedmann and Schwartz, 2012 and this statement from ISAJE.

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2023
    Submission to first editorial decision (median days): 28
    Submission to acceptance (median days): 202

    Usage 2023
    Downloads: 755,413
    Altmetric mentions: 622

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.